One non-believer: Response to "Obviously Nine Believers: Actionable Germline Genetic Variants for Pre-emptive Pharmacogenetic Testing"

Basic Clin Pharmacol Toxicol. 2020 Jan;126(1):7-8. doi: 10.1111/bcpt.13336. Epub 2019 Oct 31.

Cathelijne H van der Wouden^{1

2}, Mandy H van Rhenen³, Wafa O M Jama³, Magnus Ingelman-Sundberg⁴, Volker M Lauschke⁴, Lidija Konta⁵, Matthias Schwab^{6

7}, Jesse J Swen^{1

2}, Henk-Jan Guchelaar^{1

2}

¹ Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
² Leiden Network for Personalised Therapeutics, Leiden, The Netherlands.
³ Royal Dutch Pharmacists Association (KNMP), The Hague, The Netherlands.
⁴ Department of Physiology and Pharmacology, Section of Pharmacogenetics, Biomedicum 5B Karolinska Institute, Stockholm, Sweden.
⁵ bio.logis Center for Human Genetics, Frankfurt am Main, Germany.
⁶ Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
⁷ Department of Clinical Pharmacology and Departments of Biochemistry and Pharmacy, University Tuebingen, Tuebingen, Germany.

No abstract available

Publication types